Select Lab

The Hains/Extensively Drug-Resistant (XDR) Line Probe Assay is a specialized molecular diagnostic test used to detect and identify extensively drug-resistant strains of tuberculosis (TB) bacteria. This test plays a crucial role in identifying TB infections that are resistant to multiple classes of anti-TB drugs, which is a serious concern for public health.Tuberculosis is a bacterial infection that can become resistant to commonly used antibiotics, posing challenges to effective treatment. XDR TB refers to strains that are resistant to the most potent anti-TB drugs, leaving limited options for successful treatment.During the Hains/XDR Line Probe Assay, a sample of sputum or other relevant specimen is collected from the patient. The test uses molecular techniques to identify specific genetic mutations in the TB bacteria associated with resistance to a range of anti-TB drugs. This information helps healthcare providers determine suitable treatment options.The results of the Hains/XDR Line Probe Assay provide crucial insights into the drug susceptibility of the TB bacteria present in the patient\'s sample. This information guides healthcare professionals in making informed decisions about patient care, selecting appropriate antibiotic regimens, and implementing strategies to prevent the spread of XDR TB strains.Scheduling the Hains/XDR Line Probe Assay through our online platform offers a convenient way to access advanced molecular diagnostic services. By identifying extensively drug-resistant TB strains, this test empowers healthcare providers to provide targeted and effective treatment, prevent the spread of resistant strains, and contribute to the management of drug-resistant TB in the community. Know More